These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 22743166)

  • 1. Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy.
    Rink M; Xylinas E; Margulis V; Cha EK; Ehdaie B; Raman JD; Chun FK; Matsumoto K; Lotan Y; Furberg H; Babjuk M; Pycha A; Wood CG; Karakiewicz PI; Fisch M; Scherr DS; Shariat SF;
    Eur Urol; 2013 Jun; 63(6):1082-90. PubMed ID: 22743166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender-specific effect of smoking on upper tract urothelial carcinoma outcomes.
    Rink M; Xylinas E; Trinh QD; Lotan Y; Margulis V; Raman JD; Fisch M; Lee RK; Chun FK; Abdennabi J; Seitz C; Pycha A; Zlotta AR; Karakiewicz PI; Babjuk M; Scherr DS; Shariat SF;
    BJU Int; 2013 Sep; 112(5):623-37. PubMed ID: 23465088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy.
    Xylinas E; Kluth LA; Rieken M; Lee RK; Elghouayel M; Ficarra V; Margulis V; Lotan Y; Rouprêt M; Martinez-Salamanca JI; Matsumoto K; Seitz C; Karakiewicz PI; Zerbib M; Scherr DS; Shariat SF;
    BJU Int; 2014 Jul; 114(1):56-61. PubMed ID: 24053463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.
    Rink M; Zabor EC; Furberg H; Xylinas E; Ehdaie B; Novara G; Babjuk M; Pycha A; Lotan Y; Trinh QD; Chun FK; Lee RK; Karakiewicz PI; Fisch M; Robinson BD; Scherr DS; Shariat SF
    Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma.
    Ehdaie B; Furberg H; Zabor EC; Ostroff JS; Shariat SF; Bochner BH; Coleman JA; Dalbagni G
    BJU Int; 2013 Apr; 111(4):589-95. PubMed ID: 22642265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Rieken M; Schubert T; Xylinas E; Kluth L; Rouprêt M; Trinh QD; Lee RK; Al Hussein Al Awamlh B; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Bachmann A; Shariat SF;
    Eur J Surg Oncol; 2014 Dec; 40(12):1693-9. PubMed ID: 24780094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center.
    Favaretto RL; Shariat SF; Chade DC; Godoy G; Adamy A; Kaag M; Bochner BH; Coleman J; Dalbagni G
    Eur Urol; 2010 Oct; 58(4):574-80. PubMed ID: 20637540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer.
    Rink M; Furberg H; Zabor EC; Xylinas E; Babjuk M; Pycha A; Lotan Y; Karakiewicz PI; Novara G; Robinson BD; Montorsi F; Chun FK; Scherr DS; Shariat SF
    Eur Urol; 2013 Apr; 63(4):724-32. PubMed ID: 22925575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
    Xylinas E; Rink M; Cha EK; Clozel T; Lee RK; Fajkovic H; Comploj E; Novara G; Margulis V; Raman JD; Lotan Y; Kassouf W; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Zigeuner R; Pycha A; Scherr DS; Seitz C; Walton T; Trinh QD; Karakiewicz PI; Matin S; Montorsi F; Zerbib M; Shariat SF;
    Eur Urol; 2014 Jan; 65(1):210-7. PubMed ID: 22579047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Rieken M; Xylinas E; Kluth L; Trinh QD; Lee RK; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Kautzky-Willer A; Bachmann A; Shariat SF;
    Eur J Surg Oncol; 2014 Jan; 40(1):113-20. PubMed ID: 24113620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
    Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M;
    BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant Chemotherapy.
    Fletcher SA; Pallauf M; Watts EK; Lombardo KA; Campbell JA; Rezaee ME; Rouprêt M; Boorjian SA; Potretzke AM; Roshandel MR; Ploussard G; Djaladat H; Ghoreifi A; Mari A; Campi R; Khene ZE; Raman JD; Kikuchi E; Rink M; Abdollah F; Boormans JL; Fujita K; D'Andrea D; Soria F; Breda A; Hoffman-Censits J; McConkey DJ; Shariat SF; Pradere B; Singla N
    Eur Urol Oncol; 2024 Oct; 7(5):1061-1068. PubMed ID: 38262800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma.
    Bagrodia A; Kuehhas FE; Gayed BA; Wood CG; Raman JD; Kapur P; Derweesh IH; Bensalah K; Sagalowsky AI; Shariat SF; Lotan Y; Margulis V
    Urology; 2013 May; 81(5):972-7. PubMed ID: 23523292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy.
    Ouzzane A; Colin P; Ghoneim TP; Zerbib M; De La Taille A; Audenet F; Saint F; Hoarau N; Adam E; Azemar MD; Bensadoun H; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Maurin C; Nouhaud FX; Phe V; Polguer T; Roumiguié M; Ruffion A; Rouprêt M
    World J Urol; 2013 Feb; 31(1):189-97. PubMed ID: 23229227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy.
    Chromecki TF; Cha EK; Fajkovic H; Margulis V; Novara G; Scherr DS; Lotan Y; Raman JD; Kassouf W; Bensalah K; Weizer A; Kikuchi E; Roscigno M; Remzi M; Matsumoto K; Walton TJ; Pycha A; Ficarra V; Karakiewicz PI; Zigeuner R; Pummer K; Shariat SF
    Eur Urol; 2012 Feb; 61(2):245-53. PubMed ID: 21975249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A.
    Inokuchi J; Kuroiwa K; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yamaguchi A; Matsuyama H; Ichikawa T; Asano T; Mizusawa J; Eba J; Naito S
    World J Urol; 2017 Nov; 35(11):1737-1744. PubMed ID: 28508102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma.
    Lee DJ; Xylinas E; Rieken M; Khani F; Klatte T; Wood CG; Karam JA; Weizer AZ; Raman JD; Remzi M; Guo CC; Rioux-Leclercq N; Haitel A; Bolenz C; Bensalah K; Sagalowsky AI; Montorsi F; Lotan Y; Shariat SF; Robinson BD; Margulis V
    Eur Urol; 2014 Aug; 66(2):379-85. PubMed ID: 24388440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool.
    Xylinas E; Kluth L; Passoni N; Trinh QD; Rieken M; Lee RK; Fajkovic H; Novara G; Margulis V; Raman JD; Lotan Y; Rouprêt M; Aziz A; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Walton T; Karakiewicz PI; Montorsi F; Zerbib M; Scherr DS; Shariat SF;
    Eur Urol; 2014 Mar; 65(3):650-8. PubMed ID: 24070577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial Carcinoma.
    Martini A; Lonati C; Nocera L; Fallara G; Raggi D; Herout R; Zamboni S; Ploussard G; Predere B; Mattei A; Simeone C; Krajewski W; Simone G; Soria F; Gontero P; Roupret M; Montorsi F; Briganti A; Shariat SF; Necchi A; Moschini M
    Eur Urol Oncol; 2022 Aug; 5(4):451-459. PubMed ID: 35504834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
    Seisen T; Peyronnet B; Dominguez-Escrig JL; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Cowan NC; Kaasinen E; Palou J; van Rhijn BW; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
    Eur Urol; 2016 Dec; 70(6):1052-1068. PubMed ID: 27477528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.